12.3 Mucogingival Deformities, Soft Tissue Grafting & Peri-Implant Diseases (Mucositis vs. Peri-Implantitis)

Mucogingival conditions and peri-implant pathology represent two critical facets of contemporary clinical periodontics. Achieving a stable zone of keratinized attached tissue is vital for periodontal longevity and peri-implant defense. With dental implants now widely utilized, clinicians must distinguish the biological differences between natural teeth and dental implants, and execute evidence-based protocols for peri-implant diseases.

---

Attached Gingiva Width: Classical vs. Contemporary Evidence

                  GINGIVAL ANATOMICAL ZONES

  Gingival Margin  ─────────────────────────────
                   │ Free (Marginal) Gingiva (~1-2 mm)
  Free Gingival Gr ─────────────────────────────  <- Base of Sulcus
                   │
                   │ ATTACHED GINGIVA
                   │ (Firmly bound to periosteum & cementum)
                   │
  Mucogingival Jct ═════════════════════════════  <- Keratinized Tissue Width
                   │ ALVEOLAR MUCOSA                 = Free + Attached
                   │ (Movable, non-keratinized, elastic)

1. Classical Lang & Löe Paradigm (1972)

• Asserted that $\ge 2\text{ mm}$ of keratinized gingiva (corresponding to $\ge 1\text{ mm}$ of firmly attached gingiva) was mandatory to maintain gingival health and prevent progressive attachment loss.

2. Modern Clinical Evidence (Wennström, Dorfman, Kennedy)

• Long-term clinical trials demonstrated that in patients maintaining meticulous, atraumatic plaque control, gingival health can be preserved indefinitely even in sites with $<1\text{ mm}$ of attached gingiva or zero attached gingiva, without progressive recession.
• Absolute Clinical Indications for Mucogingival Augmentation:
  1. Progressive gingival recession defects.
  2. Subgingival restorative margins planned in areas with thin, mobile mucosa (<2 mm keratinized tissue).
  3. Orthodontic tooth movement driving roots labially through thin cortical plates.
  4. Sites where thin mucosa impairs patient plaque removal due to sensitivity or muscle pulling.
  5. Around dental implants, where a band of $\ge 2\text{ mm}$ of keratinized mucosa significantly reduces mucosal inflammation, plaque accumulation, and marginal recession.

---

Gingival Recession Classifications: Miller vs. 2017 Cairo

Historically, the Miller Classification (1985) served as the standard, but was superseded by the 2017 AAP/EFP World Workshop Cairo Classification based on objective interproximal clinical attachment levels (CAL):

               2017 CAIRO RECESSION CLASSIFICATION

        RT1                            RT2                            RT3
   (No Interprox. Loss)           (Interprox. ≤ Buccal)          (Interprox. > Buccal)

         CEJ Intact                    Interprox. CAL                 Severe Interprox.
         Interproximally               Loss ≤ Buccal                  Bone/CAL Loss
         ┌─────────┐                   ┌─────────┐                    ┌─────────┐
         │  Tooth  │                   │  Tooth  │                    │  Tooth  │
     ════╡         ╞════           ────┤         ├───                 │         │
         │ Buccal  │                   │ Buccal  │                ────┤ Buccal  ├───
         │ Recess. │                   │ Recess. │                    │ Recess. │
         └─────────┘                   └─────────┘                    └─────────┘
     100% Root Coverage             Partial Root Coverage          Zero / Unpredictable
        Predictable                       Predictable                    Coverage

1. The Miller Classification (1985)

• Class I: Marginal recession not extending to the mucogingival junction (MGJ). No loss of interdental bone or soft tissue. 100% root coverage predictable.
• Class II: Marginal recession extending to or beyond the MGJ. No loss of interdental bone or soft tissue. 100% root coverage predictable.
• Class III: Marginal recession extending to or beyond the MGJ, accompanied by interdental bone/soft tissue loss coronal to the recession base, or tooth malpositioning. Only partial root coverage predictable.
• Class IV: Severe marginal recession extending to or beyond the MGJ, with interdental bone loss level with or apical to the base of the recession defect. Zero root coverage predictable.

2. The 2017 Cairo Classification (Contemporary Standard)

• Recession Type 1 (RT1): Gingival recession with no loss of interproximal attachment. The interproximal cementoenamel junction (CEJ) is clinically undetectable on both mesial and distal aspects. Corresponds to Miller Class I and II; 100% root coverage is clinically predictable.
• Recession Type 2 (RT2): Gingival recession associated with interproximal attachment loss. The amount of interproximal clinical attachment loss is less than or equal to the buccal clinical attachment loss (interproximal $\text{CAL} \le \text{buccal CAL}$). Corresponds to Miller Class III; partial root coverage is predictable.
• Recession Type 3 (RT3): Gingival recession associated with severe interproximal attachment loss, where the interproximal clinical attachment loss is greater than the buccal clinical attachment loss (interproximal $\text{CAL} > \text{buccal CAL}$). Corresponds to severe Miller Class III and Class IV; root coverage is clinically unpredictable.

---

Soft Tissue Grafting Modalities

                      SOFT TISSUE GRAFT COMPARISON

       FREE GINGIVAL GRAFT (FGG)            CONNECTIVE TISSUE GRAFT (SCTG)
  ═══════════════════════════════════     ═════════════════════════════════════
  • Complete Epithelium + Stroma          • Pure Submucosal Lamina Propria
  • Primary Goal: Keratinized Width       • Primary Goal: Esthetic Root Coverage
  • Donor Palatal Wound: Open             • Donor Palatal Wound: Closed (Primary)
  • Blood Supply: Recipient Bed Only      • Blood Supply: Bilaminar (Bed + Flap)
  • Esthetics: Poor ("Tire-Patch")        • Esthetics: Superior Natural Blend

1. Free Gingival Graft (FGG)

• Harvest: Harvested from the hard palate lateral to the first and second premolars. Comprises the complete surface epithelium and underlying lamina propria connective tissue (thickness: 1.0 to 1.5 mm).
• Primary Indication: Augmenting the width and thickness of keratinized attached gingiva in non-esthetic areas (e.g., mandibular anterior facial sites, premolars).
• Limitations: Unfavorable esthetic outcome—heals with a pale, keloid, "tire-patch" appearance contrasting with adjacent tissues. The donor site heals by secondary intention, causing significant post-operative pain.

2. Subepithelial Connective Tissue Graft (SCTG / CTG)

• Technique: Introduced by Langer & Langer. Harvested from the submucosa of the palate using a trap-door, single-incision, or parallel-incision technique, harvesting pure lamina propria while preserving the overlying palatal epithelium to close primarily.
• Primary Indication: Gold standard for root coverage in Cairo RT1 and RT2 defects (single and multiple adjacent teeth).
• Biological Advantage (Bilaminar Blood Supply): The graft is sandwiched between the underlying de-epithelialized periosteal bed and the overlying coronally advanced mucosal flap, receiving microvascular perfusion from both sides.
• Esthetics: Outstanding tissue color, contour, and vascular blending.

3. Advanced Flap Designs

• Coronally Advanced Flap (CAF): The primary surgical vehicle for root coverage; often used alone in thick gingival phenotypes ($>1.0\text{ mm}$) or combined with SCTG in thin phenotypes.
• Tunnel / VISTA Technique: Vestibular Incision Subperiosteal Tunnel Access. Avoids vertical incisions and preserves interdental papillae entirely; ideal for multiple adjacent recession defects in the esthetic maxilla.
• Acellular Dermal Matrix (ADM / Alloderm): Chemically de-epithelialized human allograft dermis; eliminates palatal donor harvesting morbidity, though yielding slightly less keratinized tissue than autologous SCTG.

---

Peri-Implant Biology vs. Natural Periodontium

Titanium dental implants achieve functional osseointegration, but lack the specialized supracrestal attachment of natural teeth:

          NATURAL TOOTH                              DENTAL IMPLANT

   Gingival Epithelium                        Peri-Implant Epithelium (Fragile)
           │                                                │
   Acellular Cementum                         NO Cementum (Titanium Oxide)
           │                                                │
   Sharpey's Fibers (Perpendicular)           NO Sharpey's Fibers
   - True functional insertion into root      - Fibers run Parallel / Circular
           │                                  - No physical attachment to implant
   Periodontal Ligament (PDL)                 NO PDL (Osseointegration to bone)
   - Rich vascular plexus                     - Hypovascular, scar-like mucosa
   - Ruffini mechanoreceptors                 - Devoid of proprioception
   - Resists probe penetration (0.5 mm)       - Probe penetrates to bone crest

---

Diagnostic Classification of Peri-Implant Diseases (2017 World Workshop)

                       PERI-IMPLANT HEALTH & DISEASE

     [PERI-IMPLANT HEALTH] ──> No erythema, no edema, no BOP, stable bone levels
               │
     [PERI-IMPLANT MUCOSITIS] ──> Visual inflammation, BOP present on gentle probing,
               │                  NO progressive marginal bone loss (Reversible)
               ▼
     [PERI-IMPLANTITIS] ──> Plaque-induced mucosal inflammation + BOP/Suppuration
                            + PROGRESSIVE SUPPORTING MARGINAL BONE LOSS

1. Peri-Implant Health

• Absence of clinical signs of erythema, swelling, or suppuration.
• Absence of bleeding on gentle probing (BOP) utilizing light probing force ($\le 0.25\text{ N}$).
• Stable marginal bone levels following initial physiological post-restorative remodeling (typically $\le 2.0\text{ mm}$ during the first year after functional loading).

2. Peri-Implant Mucositis

• Definition: A reversible plaque-associated inflammatory lesion localized strictly within the peri-implant mucosal cuff.
• Diagnostic Criteria: Visual signs of inflammation (erythema, edema) combined with bleeding on gentle probing (BOP) and/or suppuration, in the complete absence of progressive marginal bone loss beyond crestal remodeling.
• Reversibility: Completely resolves following thorough plaque and calculus debridement.

3. Peri-Implantitis

• Definition: A plaque-associated pathological condition occurring in the tissues surrounding dental implants, characterized by mucosal inflammation and progressive loss of supporting alveolar bone.
• Diagnostic Criteria (With Baseline Radiographs):
  1. Bleeding on probing (BOP) and/or suppuration.
  2. Increased probing depths compared to baseline examination.
  3. Documented progressive marginal bone loss exceeding initial remodeling.
• Diagnostic Criteria (In the Absence of Baseline Records):
  1. Presence of bleeding and/or suppuration on probing.
  2. Probing depths of $\ge 6\text{ mm}$.
  3. Bone levels $\ge 3\text{ mm}$ apical to the most coronal portion of the intraosseous part of the implant.

---

Management: The CIST Protocol & Surgical Therapy

The Cumulative Interceptive Supportive Therapy (CIST) protocol provides a staged therapeutic framework based on probing depth, bleeding, and bone loss:

               CIST PROTOCOL (Cumulative Interceptive Supportive Therapy)

  Probing Depth ≤ 3 mm, No BOP       ──> Protocol A: Mechanical cleaning, polishing
  Probing Depth 4-5 mm, BOP (+)      ──> Protocol A + B: Antiseptics (0.12% Chlorhexidine)
  Probing Depth ≥ 6 mm, BOP (+),     ──> Protocol A + B + C: Antimicrobials (Systemic or
  Bone Loss < 2 mm                       Local minocycline/doxycycline)
  Probing Depth ≥ 6 mm, BOP (+),     ──> Protocol A + B + C + D: Surgical Intervention
  Bone Loss ≥ 2 mm                       - Resective (Implantoplasty) OR
                                         - Regenerative (Bone graft + Membrane)
  Mobility / Complete Bone Loss      ──> Protocol E: Explantation (Implant Removal)

1. Protocol A: Mechanical Debridement

• Crucial Armamentarium: Never use conventional stainless steel or carbon steel scalers, which scratch and gouge titanium surfaces, accelerating plaque adhesion. Utilize titanium curettes, carbon fiber/polyetheretherketone (PEEK) instruments, or glycine/erythritol subgingival air-polishing.

2. Protocol B: Antiseptic Therapy

• Subgingival irrigation with 0.12% to 0.2% chlorhexidine gluconate or 3% hydrogen peroxide.

3. Protocol C: Antimicrobial Therapy

• Local sustained-release antimicrobials (e.g., minocycline microspheres) or systemic antibiotics (Amoxicillin 500 mg + Metronidazole 400 mg TID for 7 days) during acute inflammatory phases.

4. Protocol D: Surgical Intervention

• Resective Surgery with Implantoplasty: Indicated for suprabony or horizontal non-contained bone defects. A full-thickness flap is reflected, granulation tissue is debrided, and exposed contaminated rough titanium threads are mechanically ground smooth and polished using high-speed diamond and carbide burs (implantoplasty), converting a plaque-retentive surface into a cleansable smooth finish.
• Regenerative Surgery: Indicated for deep, circumferential, 2-to-3-wall crater-like intrabony defects. Surface decontamination (via titanium brushes, citric acid, or air-abrasion) is followed by graft placement (ABBM) and a bioabsorbable collagen membrane.

5. Protocol E: Explantation

• Any dental implant exhibiting clinical mobility has suffered a complete breakdown of osseointegration and must be extracted immediately.